Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin

Abstract Hemagglutinin (HA)-based current vaccines provide suboptimum cross protection. Influenza A virus contains an ion channel protein M2 conserved extracellular domain (M2e), a target for developing universal vaccines. Here we generated reassortant influenza virus rgH3N2 4xM2e virus (HA and NA f...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bo Ryoung Park, Ki-Hye Kim, Tatiana Kotomina, Min-Chul Kim, Young-Man Kwon, Subbiah Jeeva, Yu-Jin Jung, Noopur Bhatnagar, Irina Isakova-Sivak, Daria Mezhenskaya, Larisa Rudenko, Bao-Zhong Wang, Sang-Moo Kang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/de27ac60c5a6402b8c6c3bb5e7a6fea3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:de27ac60c5a6402b8c6c3bb5e7a6fea3
record_format dspace
spelling oai:doaj.org-article:de27ac60c5a6402b8c6c3bb5e7a6fea32021-12-02T10:54:31ZBroad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin10.1038/s41598-021-83704-02045-2322https://doaj.org/article/de27ac60c5a6402b8c6c3bb5e7a6fea32021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83704-0https://doaj.org/toc/2045-2322Abstract Hemagglutinin (HA)-based current vaccines provide suboptimum cross protection. Influenza A virus contains an ion channel protein M2 conserved extracellular domain (M2e), a target for developing universal vaccines. Here we generated reassortant influenza virus rgH3N2 4xM2e virus (HA and NA from A/Switzerland/9715293/2013/(H3N2)) expressing chimeric 4xM2e-HA fusion proteins with 4xM2e epitopes inserted into the H3 HA N-terminus. Recombinant rgH3N2 4xM2e virus was found to retain equivalent growth kinetics as rgH3N2 in egg substrates. Intranasal single inoculation of mice with live rgH3N2 4xM2e virus was effective in priming the induction of M2e specific IgG antibody responses in mucosal and systemic sites as well as T cell responses. The rgH3N2 4xM2e primed mice were protected against a broad range of different influenza A virus subtypes including H1N1, H3N2, H5N1, H7N9, and H9N2. The findings support a new approach to improve the efficacy of current vaccine platforms by recombinant influenza virus inducing immunity to HA and cross protective M2e antigens.Bo Ryoung ParkKi-Hye KimTatiana KotominaMin-Chul KimYoung-Man KwonSubbiah JeevaYu-Jin JungNoopur BhatnagarIrina Isakova-SivakDaria MezhenskayaLarisa RudenkoBao-Zhong WangSang-Moo KangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Bo Ryoung Park
Ki-Hye Kim
Tatiana Kotomina
Min-Chul Kim
Young-Man Kwon
Subbiah Jeeva
Yu-Jin Jung
Noopur Bhatnagar
Irina Isakova-Sivak
Daria Mezhenskaya
Larisa Rudenko
Bao-Zhong Wang
Sang-Moo Kang
Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin
description Abstract Hemagglutinin (HA)-based current vaccines provide suboptimum cross protection. Influenza A virus contains an ion channel protein M2 conserved extracellular domain (M2e), a target for developing universal vaccines. Here we generated reassortant influenza virus rgH3N2 4xM2e virus (HA and NA from A/Switzerland/9715293/2013/(H3N2)) expressing chimeric 4xM2e-HA fusion proteins with 4xM2e epitopes inserted into the H3 HA N-terminus. Recombinant rgH3N2 4xM2e virus was found to retain equivalent growth kinetics as rgH3N2 in egg substrates. Intranasal single inoculation of mice with live rgH3N2 4xM2e virus was effective in priming the induction of M2e specific IgG antibody responses in mucosal and systemic sites as well as T cell responses. The rgH3N2 4xM2e primed mice were protected against a broad range of different influenza A virus subtypes including H1N1, H3N2, H5N1, H7N9, and H9N2. The findings support a new approach to improve the efficacy of current vaccine platforms by recombinant influenza virus inducing immunity to HA and cross protective M2e antigens.
format article
author Bo Ryoung Park
Ki-Hye Kim
Tatiana Kotomina
Min-Chul Kim
Young-Man Kwon
Subbiah Jeeva
Yu-Jin Jung
Noopur Bhatnagar
Irina Isakova-Sivak
Daria Mezhenskaya
Larisa Rudenko
Bao-Zhong Wang
Sang-Moo Kang
author_facet Bo Ryoung Park
Ki-Hye Kim
Tatiana Kotomina
Min-Chul Kim
Young-Man Kwon
Subbiah Jeeva
Yu-Jin Jung
Noopur Bhatnagar
Irina Isakova-Sivak
Daria Mezhenskaya
Larisa Rudenko
Bao-Zhong Wang
Sang-Moo Kang
author_sort Bo Ryoung Park
title Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin
title_short Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin
title_full Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin
title_fullStr Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin
title_full_unstemmed Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin
title_sort broad cross protection by recombinant live attenuated influenza h3n2 seasonal virus expressing conserved m2 extracellular domain in a chimeric hemagglutinin
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/de27ac60c5a6402b8c6c3bb5e7a6fea3
work_keys_str_mv AT boryoungpark broadcrossprotectionbyrecombinantliveattenuatedinfluenzah3n2seasonalvirusexpressingconservedm2extracellulardomaininachimerichemagglutinin
AT kihyekim broadcrossprotectionbyrecombinantliveattenuatedinfluenzah3n2seasonalvirusexpressingconservedm2extracellulardomaininachimerichemagglutinin
AT tatianakotomina broadcrossprotectionbyrecombinantliveattenuatedinfluenzah3n2seasonalvirusexpressingconservedm2extracellulardomaininachimerichemagglutinin
AT minchulkim broadcrossprotectionbyrecombinantliveattenuatedinfluenzah3n2seasonalvirusexpressingconservedm2extracellulardomaininachimerichemagglutinin
AT youngmankwon broadcrossprotectionbyrecombinantliveattenuatedinfluenzah3n2seasonalvirusexpressingconservedm2extracellulardomaininachimerichemagglutinin
AT subbiahjeeva broadcrossprotectionbyrecombinantliveattenuatedinfluenzah3n2seasonalvirusexpressingconservedm2extracellulardomaininachimerichemagglutinin
AT yujinjung broadcrossprotectionbyrecombinantliveattenuatedinfluenzah3n2seasonalvirusexpressingconservedm2extracellulardomaininachimerichemagglutinin
AT noopurbhatnagar broadcrossprotectionbyrecombinantliveattenuatedinfluenzah3n2seasonalvirusexpressingconservedm2extracellulardomaininachimerichemagglutinin
AT irinaisakovasivak broadcrossprotectionbyrecombinantliveattenuatedinfluenzah3n2seasonalvirusexpressingconservedm2extracellulardomaininachimerichemagglutinin
AT dariamezhenskaya broadcrossprotectionbyrecombinantliveattenuatedinfluenzah3n2seasonalvirusexpressingconservedm2extracellulardomaininachimerichemagglutinin
AT larisarudenko broadcrossprotectionbyrecombinantliveattenuatedinfluenzah3n2seasonalvirusexpressingconservedm2extracellulardomaininachimerichemagglutinin
AT baozhongwang broadcrossprotectionbyrecombinantliveattenuatedinfluenzah3n2seasonalvirusexpressingconservedm2extracellulardomaininachimerichemagglutinin
AT sangmookang broadcrossprotectionbyrecombinantliveattenuatedinfluenzah3n2seasonalvirusexpressingconservedm2extracellulardomaininachimerichemagglutinin
_version_ 1718396498175066112